BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32586174)

  • 21. Hormone replacement therapy with GnRH agonist pretreatment improves pregnancy outcomes in patients with previous intrauterine adhesions.
    Mo M; Zheng Q; Zhang H; Xu S; Xu F; Wang Y; Zeng Y
    J Gynecol Obstet Hum Reprod; 2022 Oct; 51(8):102439. PubMed ID: 35820621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy outcomes in women with adenomyosis, undergoing artificial endometrial preparation with and without gonadotropin-releasing hormone agonist pretreatment in frozen embryo transfer cycles: An RCT.
    Eslami Moayed M; Moini A; Kashani L; Farid Mojtahedi M; Rezaee T; Tabasizadeh H; Maajani K; Yamini N
    Int J Reprod Biomed; 2023 Jun; 21(6):481-490. PubMed ID: 37560066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Pregnancy and Neonatal Outcomes of Single Frozen Blastocyst Transfer Between Letrozole-Induction and HRT Cycles in Patients With Abnormal Ovulation.
    Zhang J; Li Z; Sun L; Guan Y; Du M
    Front Endocrinol (Lausanne); 2021; 12():664072. PubMed ID: 33935972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel strategy of using corifollitropin alfa in the ultrashort gonadotropin-releasing hormone agonist (GnRHa) protocol in unselected patients: A patient-friendly alternative.
    Yu TN; Liu YL; Wang PH; Chen CH; Chen CH; Tzeng CR
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):656-661. PubMed ID: 31542088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Young women were associated with higher risk of hypertensive disorders of pregnancy and cesarean section from hormone replaced cycles in frozen-thawed embryo transfer: a retrospective study of 5316 singleton deliveries.
    Hu X; Liao Z; Li J; Zhou Y; Guo Y; Qian K
    Front Endocrinol (Lausanne); 2023; 14():1238887. PubMed ID: 37772083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer.
    Li SJ; Zhang YJ; Chai XS; Nie MF; Zhou YY; Chen JL; Tao GS
    Arch Gynecol Obstet; 2014 Mar; 289(3):687-93. PubMed ID: 24121690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mid-luteal phase gonadotropin-releasing hormone agonist support in frozen-thawed embryo transfers during artificial cycles: A prospective interventional pilot study.
    Seikkula J; Ahinko K; Polo-Kantola P; Anttila L; Hurme S; Tinkanen H; Jokimaa V
    J Gynecol Obstet Hum Reprod; 2018 Oct; 47(8):391-395. PubMed ID: 29684629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy outcomes after frozen-thawed single euploid blastocyst transfer following IVF cycles using GNRH agonist or HCG trigger for final oocyte maturation.
    Makhijani R; Thorne J; Bartels C; Bartolucci A; Nulsen J; Grow D; Benadiva C; Engmann L
    J Assist Reprod Genet; 2020 Mar; 37(3):611-617. PubMed ID: 31897845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstetric and neonatal outcomes after programmed frozen embryo transfer with or without GnRH agonist for polycystic ovary syndrome: secondary analysis results from a randomized controlled trial.
    Jie HY; Hu R; Zhang L; Dong K; Wu C; Wang Q; Luo L
    AJOG Glob Rep; 2023 May; 3(2):100201. PubMed ID: 37168544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial Cycle with or without a Depot Gonadotropin-releasing Hormone Agonist for Frozen-thawed Embryo Transfer: An Assessment of Infertility Type that Is Most Suitable.
    Xie D; Chen F; Xie SZ; Chen ZL; Tuo P; Zhou R; Zhang J
    Curr Med Sci; 2018 Aug; 38(4):626-631. PubMed ID: 30128871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen dose tapering during luteal phase does not affect clinical outcomes after hormone replacement treatment-frozen-thawed embryo transfer cycles: a retrospective analysis.
    Jing Z; Xi H; Qianling Z; Lunquan S; Nenghui L; Yanping L
    Hum Reprod; 2019 Aug; 34(8):1479-1484. PubMed ID: 31310320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist.
    Ji H; Su Y; Zhang M; Li X; Li X; Ding H; Dong L; Cao S; Zhao C; Zhang J; Shen R; Ling X
    Front Endocrinol (Lausanne); 2022; 13():828993. PubMed ID: 35574002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study.
    Aflatoonian A; Mansoori-Torshizi M; Farid Mojtahedi M; Aflatoonian B; Khalili MA; Amir-Arjmand MH; Soleimani M; Aflatoonian N; Oskouian H; Tabibnejad N; Humaidan P
    Int J Reprod Biomed; 2018 Jan; 16(1):9-18. PubMed ID: 29675483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal outcomes of neonates born from different endometrial preparation protocols after frozen embryo transfer: a retrospective cohort study.
    Li C; He YC; Xu JJ; Wang Y; Liu H; Duan CC; Shi CY; Chen L; Wang J; Sheng JZ; Huang HF; Wu YT
    BMC Pregnancy Childbirth; 2021 Apr; 21(1):341. PubMed ID: 33926401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pregnancy rates among anovulatory and oligoovulatory women after letrozole versus hormone replacement therapy in frozen-thawed embryo transfer cycles.
    Sharon-Weiner M; Farladansky-Gershnabel S; Schreiber H; Shavit T; Levitas E; Berkovitz A
    Hum Fertil (Camb); 2023 Feb; 26(1):107-114. PubMed ID: 34369243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal Replacement Treatment for Frozen-Thawed Embryo Transfer With or Without GnRH Agonist Pretreatment: A Retrospective Cohort Study Stratified by Times of Embryo Implantation Failures.
    Xia L; Tian L; Zhang S; Huang J; Wu Q
    Front Endocrinol (Lausanne); 2022; 13():803471. PubMed ID: 35185793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
    Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
    Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cycle regimens for frozen-thawed embryo transfer.
    Ghobara T; Vandekerckhove P
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003414. PubMed ID: 18254019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.